» Articles » PMID: 38985355

Risk Factors of Prognosis for Spontaneous Cerebellar Hemorrhage: a Systematic Review and Meta-analysis

Overview
Specialty Neurosurgery
Date 2024 Jul 10
PMID 38985355
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The most deadly type of spontaneous intracerebral hemorrhage is spontaneous cerebellar hemorrhage (SCH). The purpose of this meta-analysis was to investigate risk factors for prognosis in SCH patients to provide a basis for taking preventive and therapeutic measures.

Methods: Seven electronic databases were searched from inception to May 2023 for randomized controlled trial, cohort study, case control study and cross-sectional study on prognosis of spontaneous cerebellar hemorrhage. The quality of the selected studies were assessed by the American Agency for Healthcare Research and Quality (AHRQ). To assess the impact of the included risk factors on the prognosis of spontaneous cerebellar hemorrhage, combined odds ratios (ORs) with matching 95% confidence intervals (CIs) were combined.

Results: Eight studies were included, including 539 participants. And a total of 31 potentially associated risk factors were identified. Ultimately, 6 risk factors were included in the meta-analysis after assessing. The factors supported by moderate evidence include the hydrocephalus (OR = 4.3, 95% CI: 2.33 to 7.91) and drug-induced coagulopathy (OR = 2.74, 95% CI: 1.23 to 6.09). The factors supported by limited evidence include the intraventricular bleeding(OR = 1.86, 95% CI: 1.13 to 3.07) and hematoma size>3 cm(OR = 3.18, 95% CI: 1.87 to 5.39). Meta-analysis revealed no association between hypertension, diabetes mellitus and SCH prognosis.

Conclusion: The current meta-analysis revealed obvious risk factors for prognosis in spontaneous cerebellar hemorrhage patients, including hydrocephalus, drug-induced coagulopathy, intraventricular bleeding and hematoma size>3 cm.

References
1.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

2.
Cohen Z, Ram Z, Knoller N, Peles E, Hadani M . Management and outcome of non-traumatic cerebellar haemorrhage. Cerebrovasc Dis. 2002; 14(3-4):207-13. DOI: 10.1159/000065666. View

3.
Flaherty M, Woo D, Haverbusch M, Sekar P, Khoury J, Sauerbeck L . Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005; 36(5):934-7. DOI: 10.1161/01.STR.0000160756.72109.95. View

4.
Wu Y, Li T, Chiang S, Chu H, Chang S, Chen L . Predictors of first-week mortality in patients with acute spontaneous cerebellar hemorrhage. Cerebellum. 2012; 12(2):165-70. DOI: 10.1007/s12311-012-0410-6. View

5.
Steiner T, Poli S, Griebe M, Husing J, Hajda J, Freiberger A . Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol. 2016; 15(6):566-73. DOI: 10.1016/S1474-4422(16)00110-1. View